
TAT Protein Transduction Peptide Mediated Heterologous Proteins Transduction in C.elegans
WU Yong-hong, SHI Jin-ping, HE Guo-wei, REN Chang-hong, GAO Yan, ZHANG Cheng-gang
China Biotechnology ›› 2011, Vol. 31 ›› Issue (03) : 39-45.
TAT Protein Transduction Peptide Mediated Heterologous Proteins Transduction in C.elegans
The TAT protein transduction peptide was enriched in basic amino acids and encoded by the HIV-1 virus. Previous studies have revealed that it could safely and efficiently mediate various heterologous biological macromolecules across a variety of biomembranes, such as the plasmid membrane and the blood-brain barrier et al. To further study its function in mediating heterologous proteins transduction in nematode in vivo, the prokaryotic expression vector pET28b-EGFP and pET28b-TAT-EGFP were constructed and induced by IPTG (final concentration 1 mmol/L), followed with the analysis on the expressed protein by fluorescence microscopy, SDS-PAGE and Western blot. Subsequently, the bacterial cells were coated to the LB medium and directly fed to the nematodes followed with capturing the image at 48 h. Results showed when fed to the nematodes for 48 h, the TAT-EGFP fluorescence signals were clearly distributed in the intestinal cells of the worm, while the EGFP fluorescence signals were mainly distributed in the intestinal cavity of the animal. Furthermore, the cellular morphology of TAT-EGFP had no distinct change compared with the EGFP group and controls. Taken together, the data suggested the TAT protein transduction peptide could mediate heterologous protein expression in C.elegans and provided an alternative approach for development of new drug transporter.
TAT protein transduction peptide / Prokaryotic expression / C.elegans / Transmembrane transduction {{custom_keyword}} /
[1] Greer E L, Maures T J, Hauswirth A G, et al. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C.elegans. Nature,2010,466(7304):383-387.
[2] Rieckher M, Kourtis N, Pasparaki A, et al. Transgenesis in Caenorhabditis elegans. Methods Mol Biol. 2009, 561(1):21-39.
[3] Shyu Y J, Hiatt S M, Duren H M,et al. Visualization of protein interactions in living Caenorhabditis elegans using bimolecular fluorescence complementation analysis. Nat Protoc,2008, 3(4):588-596.
[4] Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem, 1997, 272(25):16010-16017.
[5] Palm-Apergi C, Eguchi A, Dowdy S F. PTD-DRBD siRNA delivery. Methods Mol Biol,2011,683(4):339-347.
[6] 吴永红, 张成岗. HIV-1 TAT蛋白转导肽的研究进展, 中国生物工程杂志, 2010, 30(10):1006-1014. Wu Y, Zhang C.China Biotechnology, 2010, 30(10):1006-1014.
[7] Green M, Loewenstein P M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 1988, 55(6):1179-1188.
[8] Frankel A D, Pabo C O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 1988, 55(6):1189-1193.
[9] Derossi D, Joliot A H, Chassaing G. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem, 1994, 269(14):10444-10450.
[10] Han K, Jeon M J, Kim S H. Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides. Mol Cells, 2001, 12(2):267-271.
[11] Jin L H, Bahn J H, Eum W S, et al. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med, 2001, 31(11):1509-1519.
[12] Park J, Ryu J, Jin L H, et al. 9-polylysine protein transduction domain:enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin. Mol Cells, 2002, 13(2):202-208.
[13] Schwarze S R, Dowdy S F. In vivo protein transduction:intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci, 2000, 21(11):45-48.
[14] Rapoport M, Salman L, Sabag O, et al. Successful TAT-mediated enzyme replacement therapy in a mouse model of mitochondrial E3 deficiency. J Mol Med,2010 Nov 16. .
[15] Muniz L, Egloff S, Ughy B, et al. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat. PLoS Pathog,2010, 6(10):e1001152.
[16] 陈菁, 刘树滔, 饶平凡, 等. PTD-Tat之C端融合在活体体内的跨膜递送作用. 福州大学学报, 2006, 34(2):301-304. Chen J, Liu S T, Rao P F, et al. Journal of Fuzhou University, 2006, 34(2):301-304.
[17] Wu Y H, Ren C H , Gao Y et al. A novel method for promoting heterologous protein expression in Escherichia coli by fusion with the HIV-1 TAT core domain. Amino Acids, 2010, 39(3):811-820.
[18] Fawell S, Seery J, Daikh Y, et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A, 1994, 91(2):664-668.
[19] Torchilin V P, Rammohan R, Weissig V, et al. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A, 2001, 98(15):8786-8791.
[20] Lewin M, Carlesso N, Tung C H, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol, 2000, 18(4):410-414.
/
〈 |
|
〉 |